• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉输注持续时间对组织药物浓度分布的影响。

Influence of intravenous infusion duration on the tissue drug concentration profile.

作者信息

Uccellini D A, Raymond K, Morgan D J

出版信息

J Pharmacokinet Biopharm. 1986 Jun;14(3):323-34. doi: 10.1007/BF01106710.

DOI:10.1007/BF01106710
PMID:3783449
Abstract

The influence of intravenous infusion duration of a single dose of drug on the time course of drug concentration in the peripheral compartment of the classical two-compartment pharmacokinetic model was studied by computer simulation. The aim was to illustrate the general relationships among infusion duration T, dose, minimum effective concentration MEC at the effector (tissue) site, maximum tissue drug concentration C2,max, and the duration of effective tissue concentrations tD,tiss for those drugs where there is an equilibration delay between concentration at the effector site and plasma. Simulations of C2,max vs. T for meperidine, sulfamethoxazole, ampicillin, and metronidazole showed that, although maximum plasma concentration may decrease markedly with increasing T, C2,max decreased only slightly with increasing T. Simulations of the influence of T on the duration of effective plasma concentrations tD and tD,tiss of metronidazole showed that for a given T, tD,tiss may be greater than or less than tD, depending on the dose, and that it is possible to obtain effective concentrations in the tissue compartment even though the infusion duration is too long to achieve effective concentrations in plasma. It was found that, depending on the dose, it was possible to cause an increase in tD,tiss compared with bolus administration by increasing the infusion duration of the dose. It was also found that increasing T could cause opposite changes in tD and tD,tiss (compared with bolus administration, respectively), e.g., an increase in tD and a decrease in tD,tiss or vice versa, depending on the dose. It should thus be possible to make precise predictions of the influence of T on drug concentration at the effector site for individual drugs by incorporating effect compartment modeling into the analysis.

摘要

通过计算机模拟研究了单剂量药物静脉输注持续时间对经典二室药代动力学模型外周室药物浓度时程的影响。目的是阐明输注持续时间T、剂量、效应(组织)部位的最低有效浓度MEC、最大组织药物浓度C2,max以及效应部位与血浆浓度之间存在平衡延迟的那些药物的有效组织浓度持续时间tD,tiss之间的一般关系。对哌替啶、磺胺甲恶唑、氨苄西林和甲硝唑的C2,max与T的模拟表明,尽管最大血浆浓度可能随T的增加而显著降低,但C2,max仅随T的增加而略有降低。对T对甲硝唑有效血浆浓度持续时间tD和tD,tiss的影响的模拟表明,对于给定的T,tD,tiss可能大于或小于tD,这取决于剂量,并且即使输注持续时间过长以至于无法在血浆中达到有效浓度,也有可能在组织室中获得有效浓度。研究发现,根据剂量,通过增加剂量的输注持续时间,与推注给药相比,有可能使tD,tiss增加。还发现增加T可能导致tD和tD,tiss发生相反的变化(分别与推注给药相比),例如,tD增加而tD,tiss减少,反之亦然,这取决于剂量。因此,通过将效应室建模纳入分析,应该能够对T对个体药物效应部位药物浓度的影响做出精确预测。

相似文献

1
Influence of intravenous infusion duration on the tissue drug concentration profile.静脉输注持续时间对组织药物浓度分布的影响。
J Pharmacokinet Biopharm. 1986 Jun;14(3):323-34. doi: 10.1007/BF01106710.
2
The effect of duration of intravenous infusion on maximum and threshold blood concentration for drugs exhibiting biexponential elimination kinetics.
J Pharmacokinet Biopharm. 1982 Feb;10(1):93-107. doi: 10.1007/BF01059185.
3
Relationships among duration of infusion, dose, dosing interval, and steady-state plasma concentrations during intermittent intravenous infusions: studies with metronidazole.间歇静脉输注期间输注持续时间、剂量、给药间隔与稳态血浆浓度之间的关系:甲硝唑研究
J Pharmacokinet Biopharm. 1986 Feb;14(1):95-106. doi: 10.1007/BF01059286.
4
Pharmacokinetic parameters relevant to recovery from opioids.与阿片类药物恢复相关的药代动力学参数。
Anesthesiology. 1994 Oct;81(4):833-42. doi: 10.1097/00000542-199410000-00010.
5
The effect of infusion time on the time course of drug concentration in blood.
J Pharmacokinet Biopharm. 1980 Dec;8(6):573-82. doi: 10.1007/BF01060054.
6
Kinetics of drug action in disease states. XXI. Relationship between drug infusion rate and dose required to produce a pharmacologic effect.疾病状态下药物作用的动力学。二十一。药物输注速率与产生药理效应所需剂量之间的关系。
J Pharm Sci. 1987 Jul;76(7):516-20. doi: 10.1002/jps.2600760705.
7
On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.传统非房室方程估算基本药代动力学参数的准确性及基于正常受试者数据预测肥胖患者稳态分布容积。
J Pharm Sci. 2011 Jun;100(6):2482-97. doi: 10.1002/jps.22444. Epub 2011 Jan 19.
8
Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models.
J Pharmacokinet Biopharm. 1979 Feb;7(1):117-25. doi: 10.1007/BF01059446.
9
Influence of administration rate on propofol plasma-effect site equilibration.给药速率对丙泊酚血浆-效应室平衡的影响。
Anesthesiology. 2007 Sep;107(3):386-96. doi: 10.1097/01.anes.0000278902.15505.f8.
10
Consecutive intravenous infusions: simulation of two compartment pharmacokinetic drugs.连续静脉输注:二室药代动力学药物的模拟
Comput Programs Biomed. 1980 Dec;12(2-3):96-104. doi: 10.1016/0010-468x(80)90055-0.

引用本文的文献

1
Influence of the rate of intravenous administration of eliprodil (SL 82.0715), a new anti-ischaemic agent, on its distribution in rat plasma and tissues.新型抗缺血药物依利罗地(SL 82.0715)静脉给药速率对其在大鼠血浆和组织中分布的影响。
J Pharmacokinet Biopharm. 1995 Apr;23(2):147-61. doi: 10.1007/BF02354269.

本文引用的文献

1
High-dose metronidazole: pharmacokinetics and bioavailability using an iv preparation and application of its use as a radiosensitizer.
Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1087-95.
2
The effect of infusion time on the time course of drug concentration in blood.
J Pharmacokinet Biopharm. 1980 Dec;8(6):573-82. doi: 10.1007/BF01060054.
3
The effect of duration of intravenous infusion on maximum and threshold blood concentration for drugs exhibiting biexponential elimination kinetics.
J Pharmacokinet Biopharm. 1982 Feb;10(1):93-107. doi: 10.1007/BF01059185.
4
Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.理解剂量-效应关系:药代动力学-药效学模型的临床应用
Clin Pharmacokinet. 1981 Nov-Dec;6(6):429-53. doi: 10.2165/00003088-198106060-00002.
5
Kinetics of pharmacologic response.药理反应动力学
Pharmacol Ther. 1982;16(2):143-66. doi: 10.1016/0163-7258(82)90051-1.
6
Simultaneous modeling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamic model.使用非参数药效学模型对药代动力学和药效学进行同步建模。
Clin Pharmacol Ther. 1984 Jun;35(6):733-41. doi: 10.1038/clpt.1984.104.
7
Correlation of performance test scores with "tissue concentration" of lysergic acid diethylamide in human subjects.人体受试者中麦角酸二乙酰胺的性能测试分数与“组织浓度”的相关性。
Clin Pharmacol Ther. 1968 Sep-Oct;9(5):635-8. doi: 10.1002/cpt196895635.
8
Pharmacokinetics of ampicillin in cirrhosis.氨苄西林在肝硬化患者中的药代动力学。
Clin Pharmacol Ther. 1975 Oct;18(4):475-84. doi: 10.1002/cpt1975184475.
9
Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children.茶碱对哮喘儿童肺功能影响的药代动力学分析
J Pediatr. 1975 May;86(5):789-93. doi: 10.1016/s0022-3476(75)80374-x.
10
Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.线性药代动力学方程允许根据已拟合数据的多指数方程的系数和指数直接计算许多所需的药代动力学参数。
J Pharmacokinet Biopharm. 1976 Oct;4(5):443-67. doi: 10.1007/BF01062831.